Phio Pharma Insider Buys 200K Shares, Boosts Confidence in Oncology Immunotherapy
Phio Pharmaceuticals’ insider buying spurs confidence in its oncology pipeline, yet investors must watch clinical milestones and funding moves for real value.
4 minutes to read